NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
RIVM and TNO describe impact of future developments on occupational health and safety RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work? iStock
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Safe working practices: RIVM creates a list of 1,400 substances without a European occupational exposure limit for health purposes Employees sometimes come into contact with hazardous substances at work. RIVM has compiled a list of 1,400 hazardous substances for which the European Commission has not yet set an occupational exposure limit.
NS did not adequately protect employees from exposure to chromium (VI) Employees of Dutch Railways (NS) may have been exposed to chromium (VI) between 1970 and 2020. Although it is not known exactly how often or how much this occurred, it is reasonable to assume that NS employees who were exposed to chromium (VI) may develop certain medical conditions.
Incidence of infections that cause gastrointestinal symptoms on the rise again In 2021, the incidence of enteric infections – which mainly cause gastrointestinal symptoms – was higher than in 2020, but still lower than before the coronavirus pandemic. This is the outcome of a study into enteric infections and pathogens transmitted from animals to humans.
Cancer screening programmes now more accessible to transgender and intersex persons Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.
From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26 From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Tailor-made information will help immigrants make decisions on taking part in screening programmes Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.
The 13-week scan now available for pregnant women Since 1 September, pregnant women in the Netherlands can have an early ultrasound scan to detect physical abnormalities in their unborn child: the 13-week scan.